Atlas Trials

Phase 2a Study to Evaluate IcBD-01 Enema in Active Ulcerative Colitis Patients

Clinical trial NCT06353828 · UNKNOWN

Trial details

NCT number
NCT06353828
Sponsor
CannaMore Biotechs
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2023-03-01
Primary completion
2024-04-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.